Intelligent Sexual Health Information Support System for Gynecological Cancer Patients
NCT07794098
Summary
This study aims to develop the LillyBot Smart Sexual Health Consultation System, designed to meet the sexual health learning and consultation needs of gynecological cancer (GC) patients in Taiwan. Grounded in the Transtheoretical Model (TTM), this system integrates AI chatbot technology and mobile health (mHealth) to provide real-time, personalized sexual health education and consultations, ultimately improving the overall sexual well-being of GC patients.
Eligibility
Inclusion Criteria: * Women diagnosed with gynecologic cancer within 6 months prior to enrollment. * Women receiving cancer treatment at the recruiting hospital. * Aged 20 to 70 years, inclusive. * Have a regular partner. * Possesses and is able to use an internet-enabled mobile device (such as a smartphone or iPad). * Able to clearly communicate and read/write in Mandarin or Taiwanese. Exclusion Criteria: * History of other malignant tumors. * Intellectual disability or mental disorders.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07794098